ArticleJournal of epidemiology and global health2025
Epidemiology of Human Papillomavirus in Saudi Arabia: A Scoping Review of Prevalence, Genotypes, and Risk Factors.
Article in Journal of epidemiology and global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHuman papillomavirus (HPV) is the most common sexually transmitted infection worldwide and a leading cause of cervical, anogenital, and oropharyngeal cancers. While global epidemiology is well-documented, data from Saudi Arabia remain fragmented. Updated evidence is essential to guide national prevention and vaccination strategies.
methodsWe systematically searched PubMed, Embase, Web of Science, MEDLINE, and Google Scholar for studies reporting HPV prevalence, genotypes, or risk factors in Saudi Arabia. Eligible studies included cross-sectional, cohort, and case-control designs assessing cervical, anal, oral, or penile HPV using validated molecular methods. Data on study characteristics, prevalence, genotypes, risk factors, and prognostic outcomes were extracted. Reporting followed PRISMA-ScR guidelines.
resultsHPV prevalence ranged from 4.7% to 31.6% in general populations and up to 52.9% in high-risk groups. The most common genotypes were HPV-16, HPV-18, and other high-risk (HR) types.
conclusionHPV represents a growing public health concern in Saudi Arabia, with HR genotypes predominating. Sociodemographic and behavioral factors influence infection patterns. Large-scale, population-based studies remain limited, highlighting the need for comprehensive surveillance, vaccination programs, and targeted awareness initiatives to reduce HPV-related disease burden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.